FACTOR VIII DEFICIENCY
Clinical trials for FACTOR VIII DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new FACTOR VIII DEFICIENCY trials appear
Sign up with your email to follow new studies for FACTOR VIII DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Weekly shot aims to protect hemophilia Patients' joints
Disease control Recruiting nowThis study is testing whether a weekly preventative treatment called efanesoctocog alfa can reduce harmful swelling in the joints of people with hemophilia A. About 35 participants with existing joint swelling will receive the weekly treatment for 12 months. Doctors will use ultr…
Matched conditions: FACTOR VIII DEFICIENCY
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Massive 40-Year study launched to unlock secrets of childhood haemophilia
Knowledge-focused Recruiting nowThis is a long-term observational study that will follow 4,000 children with haemophilia A or B across Europe from birth. The goal is to collect detailed information on their bleeding patterns, joint health, and how they respond to standard treatments over time. Researchers hope …
Matched conditions: FACTOR VIII DEFICIENCY
Sponsor: PedNet Haemophilia Research Foundation • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Massive 15-Year study launches to track safety of new blood disorder drugs
Knowledge-focused Recruiting nowThis study aims to collect long-term safety and effectiveness data on treatments for various non-cancerous blood disorders, including hemophilia, von Willebrand disease, and platelet disorders. It will follow up to 3,000 participants for at least 15 years to see how newer, FDA-ap…
Matched conditions: FACTOR VIII DEFICIENCY
Sponsor: American Thrombosis and Hemostasis Network • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC